DrugPatentWatch Database Preview
Email this page to a colleagueSee Plans and Pricing
« Back to Dashboard
Nitrite is an investigational drug.
There have been 93 clinical trials for Nitrite. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2015.
The most common disease conditions in clinical trials are Hypertension, Heart Failure, and Diabetes Mellitus. The leading clinical trial sponsors are National Heart, Lung, and Blood Institute (NHLBI), University of Pittsburgh, and Aires Pharmaceuticals, Inc.
There are twenty-nine US patents protecting this investigational drug and six hundred and twenty-seven international patents.
Recent Clinical Trials for Nitrite
|Impact of NOS, COX, and ROS Inhibition on Cerebral Blood Flow Regulation||University of Wisconsin, Madison||Phase 1|
|Tongue Dysbiosis Effects on Arterial Pressure of Periodontitis Patients||Conselho Nacional de Desenvolvimento Científico e Tecnológico||Phase 4|
|Tongue Dysbiosis Effects on Arterial Pressure of Periodontitis Patients||University of Taubate||Phase 4|
Top disease conditions for Nitrite
Top clinical trial sponsors for Nitrite
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Nitrite||Start Trial||Red blood cells loaded with S-nitrosothiol and uses therefor||Duke University (Durham, NC)||Start Trial|
|Nitrite||Start Trial||.alpha.- and .beta.-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors||G. D. Searle & Co. (Chicago, IL)||Start Trial|
|Nitrite||Start Trial||Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors||G.D. Searle & Co. (Chicago, IL)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|